Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| DISCOVERY PARTNERS INTERNATIONAL INC | 85 000 | déclaré | 14 janv. 2015 | tx 1+85 000 |
| Syros Pharmaceuticals, Inc. | 0 | déclaré | 18 nov. 2024 | tx 33+1 101 083−143 418 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 18 nov. 2024 | SALE | Syros Pharmaceuticals, Inc. | 12 099 | 0.20 USD | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | — | |
| 31 oct. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6 776 | 2.09 USD | |
| 31 oct. 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | 0.00 USD | deriv |
| 03 avr. 2024 | SALE | Syros Pharmaceuticals, Inc. | 10 451 | 4.95 USD | |
| 01 avr. 2024 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 4 732 | 5.12 USD | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13 333 | — | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 02 avr. 2024 | SALE | Syros Pharmaceuticals, Inc. | 150 | 4.98 USD | |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 31 mars 2024 | EXERCISE | Syros Pharmaceuticals, Inc. | 13 333 | 0.00 USD | deriv |
| 12 déc. 2023 | SALE | Syros Pharmaceuticals, Inc. | 6 287 | 4.95 USD | |
| 06 déc. 2023 | SALE | Syros Pharmaceuticals, Inc. | 6 287 | 3.95 USD | |
| 01 nov. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 6 301 | 2.22 USD | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | — | |
| 31 oct. 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 18 875 | 0.00 USD | deriv |
| 31 juil. 2023 | SALE | Syros Pharmaceuticals, Inc. | 7 348 | 3.95 USD | |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | — | |
| 03 avr. 2023 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 623 | 2.58 USD | |
| 31 mars 2023 | EXERCISE | Syros Pharmaceuticals, Inc. | 2 000 | 0.00 USD | deriv |
| 16 févr. 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 40 000 | 0.00 USD | deriv |
| 06 oct. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 49 750 | 0.00 USD | deriv |
| 06 oct. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 37 750 | 0.00 USD | deriv |
| 01 avr. 2022 | TAX_WITHHOLDING | Syros Pharmaceuticals, Inc. | 27 281 | 1.12 USD | |
| 15 févr. 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 125 000 | 0.00 USD | deriv |